AsclepiX Therapeutics logo

AsclepiX Therapeutics


AsclepiX Therapeutics is revolutionizing the treatment of retinal diseases and cancer with a singular focus on the design, development, and delivery of novel peptides with the power to inhibit proven key disease pathways. Their peptide drug candidates tap into the body’s powerful mechanisms of maintaining homeostasis, the fundamental principle of biology to seek and maintain a condition of equilibrium or stability.


Add photos to showcase AsclepiX Therapeutics’s culture


Add AsclepiX Therapeutics’s values

Insider experiences

Share your experience of working at AsclepiX Therapeutics

Kevin Slawin
Interim Chief Executive Officer, Board Member
Aleksander S. Popel
Vice President, Research and Development
Ben Askew
Huan Sheng
Vice President, Clinical Research
Jordan J. Green
Founder, Chief Technology Advisor
Niranjan B. Pandey
Vice President, Research and Development
Quan D. Nguyen
Clinical Drug Safety Advisor
Theresa Heah
Chief Medical Officer, Executive Vice President, Operations

Add jobs to your org chart to show candidates who they’ll work with

Publish company announcements to get more exposure